These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15094594)

  • 1. [Inflammatory breast carcinoma: towards molecular characterization?].
    Charafe-Jauffret E; Tarpin C; Ginestier C; Bertucci F; Penault-Llorca F; Xerri L; Birnbaum D; Viens P; Hassoun J; Jacquemier J
    Ann Pathol; 2003 Dec; 23(6):564-9. PubMed ID: 15094594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
    Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; van Golen KL; Wu ZF; Livant D; Merajver SD
    Oncogene; 2002 May; 21(20):3172-80. PubMed ID: 12082632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.
    Marrakchi R; Khadimallah I; Ouerhani S; Gamoudi A; Khomsi F; Bouzaine H; Benamor M; Bougatef K; Mnif S; Zitoun R; Benna F; Boussen H; Rahal K; Elgaaied AB
    Cancer Invest; 2010 May; 28(4):399-407. PubMed ID: 20014943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of the inflammatory breast cancer phenotype.
    Houchens NW; Merajver SD
    Oncology (Williston Park); 2008 Dec; 22(14):1556-61; discussion 1561, 1565-8, 1576. PubMed ID: 19198217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.
    van Golen KL; Bao LW; Pan Q; Miller FR; Wu ZF; Merajver SD
    Clin Exp Metastasis; 2002; 19(4):301-11. PubMed ID: 12090470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
    Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
    J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.
    van Golen KL; Wu ZF; Qiao XT; Bao L; Merajver SD
    Neoplasia; 2000; 2(5):418-25. PubMed ID: 11191108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
    van Golen KL; Davies S; Wu ZF; Wang Y; Bucana CD; Root H; Chandrasekharappa S; Strawderman M; Ethier SP; Merajver SD
    Clin Cancer Res; 1999 Sep; 5(9):2511-9. PubMed ID: 10499627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
    van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
    Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent E-cadherin expression in inflammatory breast cancer.
    Kleer CG; van Golen KL; Braun T; Merajver SD
    Mod Pathol; 2001 May; 14(5):458-64. PubMed ID: 11353057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.
    Kleer CG; van Golen KL; Merajver SD
    Breast Cancer Res; 2000; 2(6):423-9. PubMed ID: 11250736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complex treatment of inflammatory breast cancer].
    Szántó J; Tóth J
    Magy Onkol; 2006; 50(4):303-7. PubMed ID: 17216003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; Merajver SD
    Neoplasia; 2004; 6(2):179-85. PubMed ID: 15140407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype.
    Gong Y
    Semin Oncol; 2008 Feb; 35(1):33-40. PubMed ID: 18308144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.
    Wu M; Wu ZF; Kumar-Sinha C; Chinnaiyan A; Merajver SD
    Breast Cancer Res Treat; 2004 Mar; 84(1):3-12. PubMed ID: 14999149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
    Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
    McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
    Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.